78 related articles for article (PubMed ID: 21976619)
21. Brain extracellular γ-hydroxybutyrate concentrations are decreased by L-lactate in rats: role in the treatment of overdoses.
Roiko SA; Vijay N; Felmlee MA; Morris ME
Pharm Res; 2013 May; 30(5):1338-48. PubMed ID: 23319173
[TBL] [Abstract][Full Text] [Related]
22. Overview of the proton-coupled MCT (SLC16A) family of transporters: characterization, function and role in the transport of the drug of abuse gamma-hydroxybutyric acid.
Morris ME; Felmlee MA
AAPS J; 2008 Jun; 10(2):311-21. PubMed ID: 18523892
[TBL] [Abstract][Full Text] [Related]
23. Role of monocarboxylate transporters in drug delivery to the brain.
Vijay N; Morris ME
Curr Pharm Des; 2014; 20(10):1487-98. PubMed ID: 23789956
[TBL] [Abstract][Full Text] [Related]
24. γ-Hydroxybutyrate blood/plasma partitioning: effect of physiologic pH on transport by monocarboxylate transporters.
Morse BL; Felmlee MA; Morris ME
Drug Metab Dispos; 2012 Jan; 40(1):64-9. PubMed ID: 21976619
[TBL] [Abstract][Full Text] [Related]
25. Transport of gamma-hydroxybutyrate in rat kidney membrane vesicles: Role of monocarboxylate transporters.
Wang Q; Darling IM; Morris ME
J Pharmacol Exp Ther; 2006 Aug; 318(2):751-61. PubMed ID: 16707723
[TBL] [Abstract][Full Text] [Related]
26. Monocarboxylate transporter (MCT) mediates the transport of gamma-hydroxybutyrate in human kidney HK-2 cells.
Wang Q; Lu Y; Morris ME
Pharm Res; 2007 Jun; 24(6):1067-78. PubMed ID: 17377745
[TBL] [Abstract][Full Text] [Related]
27. Mechanistic modeling of monocarboxylate transporter-mediated toxicokinetic/toxicodynamic interactions between γ-hydroxybutyrate and L-lactate.
Morse BL; Vijay N; Morris ME
AAPS J; 2014 Jul; 16(4):756-70. PubMed ID: 24854892
[TBL] [Abstract][Full Text] [Related]
28. Effects of monocarboxylate transporter inhibition on the oral toxicokinetics/toxicodynamics of γ-hydroxybutyrate and γ-butyrolactone.
Morse BL; Morris ME
J Pharmacol Exp Ther; 2013 Apr; 345(1):102-10. PubMed ID: 23392755
[TBL] [Abstract][Full Text] [Related]
29. Case series of 226 γ-hydroxybutyrate-associated deaths: lethal toxicity and trauma.
Zvosec DL; Smith SW; Porrata T; Strobl AQ; Dyer JE
Am J Emerg Med; 2011 Mar; 29(3):319-32. PubMed ID: 20825811
[TBL] [Abstract][Full Text] [Related]
30. Mechanistic toxicokinetic model for gamma-hydroxybutyric acid: inhibition of active renal reabsorption as a potential therapeutic strategy.
Felmlee MA; Wang Q; Cui D; Roiko SA; Morris ME
AAPS J; 2010 Sep; 12(3):407-16. PubMed ID: 20461486
[TBL] [Abstract][Full Text] [Related]
31. Concentration-effect relationships for the drug of abuse gamma-hydroxybutyric acid.
Felmlee MA; Roiko SA; Morse BL; Morris ME
J Pharmacol Exp Ther; 2010 Jun; 333(3):764-71. PubMed ID: 20215411
[TBL] [Abstract][Full Text] [Related]
32. Monocarboxylate transporter-mediated transport of gamma-hydroxybutyric acid in human intestinal Caco-2 cells.
Lam WK; Felmlee MA; Morris ME
Drug Metab Dispos; 2010 Mar; 38(3):441-7. PubMed ID: 19952290
[TBL] [Abstract][Full Text] [Related]
33. The drug of abuse gamma-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): characterization of SMCT-mediated uptake and inhibition.
Cui D; Morris ME
Drug Metab Dispos; 2009 Jul; 37(7):1404-10. PubMed ID: 19389857
[TBL] [Abstract][Full Text] [Related]
34. The role of the equilibrative nucleoside transporter 1 (ENT1) in transport and metabolism of ribavirin by human and wild-type or Ent1-/- mouse erythrocytes.
Endres CJ; Moss AM; Ke B; Govindarajan R; Choi DS; Messing RO; Unadkat JD
J Pharmacol Exp Ther; 2009 Apr; 329(1):387-98. PubMed ID: 19164463
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
